Bortezomib-encapsulated metal–phenolic nanoparticles for intracellular drug delivery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bortezomib-encapsulated metal–phenolic nanoparticles for intracellular drug delivery

Published:2024 Issue:36 Volume:14 Page:26176-26182
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Zhou Haidong¹^ORCID,Xu Hongyu¹,Man Jiaping²,Wang Gangxiang¹

Affiliation:

1. Department of Orthopaedics, Shengzhou People's Hospital (Shengzhou Branch of the First Affiliated Hospital of Zhejiang University School of Medicine), 666 Dangui Road, Shengzhou, 312400, P. R. China

2. MOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310058, P. R. China

Abstract

The bortezomib (BTZ)-encapsulated metal–phenolic nanoparticles were prepared by the self-assembly of BTZ, tannic acid (TA), and Fe3+, which can be used for the intracellular delivery of BTZ.

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/RA/D4RA03504F

Reference41 articles.

1. Cancer statistics, 2024

2. A History of Cancer Chemotherapy

3. Velcade®: U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior Therapy

4. Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

5. In Vitro and In Vivo Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma Cells

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP